AAN: Half of Premenopausal Women Have Menstrual Migraines
By Lori Solomon HealthDay Reporter
FRIDAY, April 19, 2024 – More than half of premenopausal women report menstrual migraine (MM), according to a study presented at the annual meeting of the American Academy of Neurology, held from April 13 to 18 in Denver.
Jessica Cirillo, from Pfizer in New York City, and colleagues estimated the prevalence of MM and identified characteristics of women with MM. The analysis included data from the 2021 U.S. National Health and Wellness Survey.
The researchers estimate that 6.2 million women have MM, with a prevalence of 31.0 percent among all women and 52.5 percent among premenopausal women. Women with MM were a mean age of 33.2 years, 52.6 percent were married/partnered, 66.6 percent were employed, and 38.2 percent had obesity. On average, reported monthly migraine attack frequency was 4.5 days and reported monthly migraine headache days were 8.4 days. More than half of women with MM (56.2 percent) had moderate-to-severe migraine-specific disability. For women with MM, 42.4 percent treated headaches using only over-the-counter medications and 48.6 percent used prescription medications. More women reported only acute migraine treatments (63.9 percent) than migraine prevention (21.1 percent). Triptans (36.7 percent; 3.9 days of use), nonsteroidal anti-inflammatory drugs (31.1 percent; 8.1days), and opioids (22.2 percent; 7.9 days) were the most common acute treatments reported.
“The first step in helping a woman with menstrual migraine is making a diagnosis; the second part is prescribing a treatment; and the third part is finding treatments patients are satisfied with and remain on to reduce disability and improve quality of life," coauthor, Jessica Ailani M.D., from Georgetown University in Washington, D.C., said in a statement.
Several authors disclosed financial ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Age at Menarche Decreasing, Time to Cycle Regularity Increasing
FRIDAY, May 31, 2024 -- The mean age at menarche has decreased and time to cycle regularity has increased with increasing birth year, according to a study published online May 29...
Overall Risk of Death Not Increased With Premenstrual Disorders
WEDNESDAY, May 29, 2024 -- Women with premenstrual disorders (PMD) do not have increased risk of early death overall, but the risks of suicide and the risks for women with...
Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine
THURSDAY, May 9, 2024 -- Diagnostic targeted Botox injections have high positive predictive value for migraine trigger site localization, according to a study published in the May...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.